Mercer Global Advisors »

Beam Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $333k 12k 27.21
2023-09-30 $276k 12k 24.08
2023-06-30 $306k 9.6k 31.89
2023-03-31 $240k 7.8k 30.65
2022-09-30 $223k 4.7k 47.62